HSE National Guideline
HSE Guideline on the Safe Handling of Cytotoxic Drugs
Topic:
Safe handling of cytotoxic drugs
Document Owner:
Chief People Officer, National HR
National Group:
National Health & Safety Function (Policy Team)
Effective From: 01 February 2022
This Guideline is intended to raise awareness among employers and employees of the occupational hazards associated with cytotoxic drugs.
Will assist in the development of the necessary risk assessments, protocols and procedures to ensure the safety, health and welfare of employees and others who may be exposed, and to provide information about legislative requirements. It is the policy of the HSE to ensure the protection of employees from the potential risks related to the exposure to cytotoxic drugs.